Prospective multicenter study shows low VTE recurrence in cancer patients treated with rivaroxaban, suggesting effective management.
VTE recurrence/worsening occurred in only a small percentage of Japanese cancer-VTE patients treated with rivaroxaban.
No takes yet. Share an insight, caveat, or question.
Tamura et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: